CL2017000533A1 - Pirrolopirimidinas para uso en la infección por el virus de la gripe - Google Patents

Pirrolopirimidinas para uso en la infección por el virus de la gripe

Info

Publication number
CL2017000533A1
CL2017000533A1 CL2017000533A CL2017000533A CL2017000533A1 CL 2017000533 A1 CL2017000533 A1 CL 2017000533A1 CL 2017000533 A CL2017000533 A CL 2017000533A CL 2017000533 A CL2017000533 A CL 2017000533A CL 2017000533 A1 CL2017000533 A1 CL 2017000533A1
Authority
CL
Chile
Prior art keywords
pyrrolopyrimidines
influenza virus
virus infection
flu
influences
Prior art date
Application number
CL2017000533A
Other languages
English (en)
Inventor
Gowan David Craig Mc
Pierre Jean-Marie Bernard Raboisson
Werner Constant Johan Embrechts
Tim Hugo Maria Jonckers
Jerôme Émile Georges Guillemont
Original Assignee
Janssen Sciences Ireland Uc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Sciences Ireland Uc filed Critical Janssen Sciences Ireland Uc
Publication of CL2017000533A1 publication Critical patent/CL2017000533A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

<p>LA INVENCIÓN SE REFIERE A COMPUESTOS QUE TIENEN LA ESTRUCTURA DE FORMULA (I) QUE SE PUEDEN UTILIZAR PARA EL TRATAMIENTO DE INFECCIONES DE LA GRIPE O CONTRA ESTAS.</p>
CL2017000533A 2014-09-08 2017-03-06 Pirrolopirimidinas para uso en la infección por el virus de la gripe CL2017000533A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14183984 2014-09-08

Publications (1)

Publication Number Publication Date
CL2017000533A1 true CL2017000533A1 (es) 2017-10-06

Family

ID=51535336

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2017000533A CL2017000533A1 (es) 2014-09-08 2017-03-06 Pirrolopirimidinas para uso en la infección por el virus de la gripe

Country Status (22)

Country Link
US (1) US9932346B2 (es)
EP (1) EP3191489B1 (es)
JP (1) JP6718451B2 (es)
KR (1) KR102531340B1 (es)
CN (1) CN106661036B (es)
AU (1) AU2015314394A1 (es)
BR (1) BR112017004524A2 (es)
CA (1) CA2957475A1 (es)
CL (1) CL2017000533A1 (es)
DK (1) DK3191489T3 (es)
EA (1) EA201790571A1 (es)
ES (1) ES2860688T3 (es)
HR (1) HRP20210038T1 (es)
HU (1) HUE053595T2 (es)
IL (1) IL250955A0 (es)
LT (1) LT3191489T (es)
MX (1) MX2017002972A (es)
PH (1) PH12017500393A1 (es)
SG (1) SG11201701621YA (es)
SI (1) SI3191489T1 (es)
WO (1) WO2016037953A1 (es)
ZA (1) ZA201701643B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20207129B (en) 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
WO2016183120A1 (en) 2015-05-13 2016-11-17 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
EP3294717B1 (en) 2015-05-13 2020-07-29 Vertex Pharmaceuticals Inc. Methods of preparing inhibitors of influenza viruses replication
EP3362451B1 (en) 2015-12-09 2023-04-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication, application methods and uses thereof
WO2017118680A1 (en) * 2016-01-07 2017-07-13 Janssen Sciences Ireland Uc Functionalized pentanoic acids for use in influenza viral infections
WO2017133665A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh 6,7-diazaindazole and 6,7-diazaindole derivatives and use in treatment, amelioration or prevention of influenza thereof
WO2017133669A1 (en) * 2016-02-05 2017-08-10 Savira Pharmaceuticals Gmbh 5, 7-diazaindole and 5, 7-diazaindazole derivatives and their use in the treatment, amelioration or prevention of influenza
CN107759571B (zh) 2016-08-16 2021-03-02 广东东阳光药业有限公司 流感病毒复制抑制剂及其使用方法和用途
CN106316886A (zh) * 2016-08-24 2017-01-11 泰州精英化成医药科技有限公司 顺式‑3‑（叔丁氧羰基氨基）环己烷甲酸的制备方法
US10647693B2 (en) 2016-08-30 2020-05-12 North & South Brother Pharmacy Investment Company Limited Inhibitors of influenza virus replication, application methods and uses thereof
CA3045371C (en) 2016-12-15 2024-05-14 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
EP4306166A3 (en) * 2016-12-23 2024-06-26 Aquinnah Pharmaceuticals Inc. Compounds, compositions and methods of use
WO2018127096A1 (en) 2017-01-05 2018-07-12 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
US10927118B2 (en) 2017-03-02 2021-02-23 Sunshine Lake Pharma Co., Ltd. Inhibitors of influenza virus replication and uses thereof
CA3059449A1 (en) 2017-04-24 2018-11-01 Cocrystal Pharma, Inc. Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replication
CN108727369B (zh) * 2017-04-25 2023-06-09 广东东阳光药业有限公司 流感病毒复制抑制剂及其用途
WO2021206877A1 (en) 2020-04-10 2021-10-14 Cocrystal Pharma, Inc. Inhibitors of norovirus and coronavirus replication
CN120118069A (zh) * 2023-12-08 2025-06-10 武汉人福创新药物研发中心有限公司 Mrgprx2拮抗剂及用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101801971A (zh) * 2005-09-30 2010-08-11 沃泰克斯药物股份有限公司 可用作janus激酶抑制剂的脱氮嘌呤
GEP20207129B (en) 2009-06-17 2020-07-10 Vertex Pharma Inhibitors of influenza viruses replication
CA2818542A1 (en) * 2010-11-19 2012-05-24 Incyte Corporation Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
AU2011343647A1 (en) * 2010-12-16 2013-05-02 Vertex Pharmaceuticals Incorporated Inhibitors of influenza viruses replication
RU2013132681A (ru) 2010-12-16 2015-01-27 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы репликации вирусов гриппа
UA118010C2 (uk) * 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу

Also Published As

Publication number Publication date
WO2016037953A1 (en) 2016-03-17
SG11201701621YA (en) 2017-03-30
CN106661036B (zh) 2022-03-15
US9932346B2 (en) 2018-04-03
HUE053595T2 (hu) 2021-07-28
BR112017004524A2 (pt) 2017-12-05
CN106661036A (zh) 2017-05-10
DK3191489T3 (da) 2021-03-29
JP2017527619A (ja) 2017-09-21
SI3191489T1 (sl) 2021-02-26
EP3191489A1 (en) 2017-07-19
PH12017500393A1 (en) 2017-07-17
IL250955A0 (en) 2017-04-30
US20170253600A1 (en) 2017-09-07
HRP20210038T1 (hr) 2021-03-05
LT3191489T (lt) 2021-01-25
CA2957475A1 (en) 2016-03-17
KR20170054420A (ko) 2017-05-17
ZA201701643B (en) 2018-12-19
JP6718451B2 (ja) 2020-07-08
MX2017002972A (es) 2017-05-30
KR102531340B1 (ko) 2023-05-10
ES2860688T3 (es) 2021-10-05
EP3191489B1 (en) 2021-01-06
ES2860688T8 (es) 2022-01-18
AU2015314394A1 (en) 2017-03-02
EA201790571A1 (ru) 2017-08-31

Similar Documents

Publication Publication Date Title
CL2017000309A1 (es) Indoles para su uso en la infección por el virus de la gripe
CL2018001960A1 (es) Pirimidinas sustituidas con arilo para su uso en la infección por virus influenza.
PH12017500393A1 (en) Pyrrolopyrimidines for use in influenza virus infection
CL2016000424A1 (es) Métodos y composiciones para el arn-guiado tratamiento de la infección por vih
CL2013003019A1 (es) Compuestos derivados de benzotiazol; composicion farmaceutica que los comprende; y su uso en el tratamiento del vih.
CL2017001209A1 (es) Inhibidor de cinasa aurora a
CL2015002335A1 (es) Derivados de 2-aminopirimidina para el tratamiento de infecciones víricas.
CL2016000493A1 (es) Inhibidores de polimerasa hcv.
CL2015001864A1 (es) Compuestos derivados de espiropirido[1,2-a]pirazina sustituidos, como inhibidores de la integrasa del vih; composicion farmaceutica que los comprende; y su uso para la profilaxis o el tratamiento de una infeccion por vih.
DOP2015000274A (es) Compuestos químicos
CO7170160A2 (es) Nuevas 6-aminoacido-heteroarildihidropirimidinas para el tratamiento y profilaxis de la infección del virus de la hepatitis b
MX2017008720A (es) Derivados y metodos para tratamiento de las infecciones por hepatitis b.
CL2014002093A1 (es) Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas.
CR20150337A (es) Derivados de pirimidinona y su uso en el tratamiento, mejora o prevencion de una enfermedad viral
CL2014001956A1 (es) Compuestos derivados de beta-lactamicos sustituidos con amidina; metodo para su preparacion; medicamento que los comprende; y su uso para el tratamiento y/o profilaxis de infecciones bacterianas.
DOP2016000336A (es) Derivados de isoindolina para uso en el tratamiento de una infeccion viral
CL2016001210A1 (es) Análogos de bicalutamida o (s)- bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis.
MX2017003205A (es) Composiciones antimicrobianas y sus metodos de uso.
EA201791174A1 (ru) Антимикотическое соединение
CL2016002879A1 (es) Composiciones farmacéuticas para tratar enfermedades infecciosas
CL2017000152A1 (es) Derivados de isoindolinona
PE20150167A1 (es) (r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
EA201891576A1 (ru) Функционализированные пентановые кислоты для применения при инфекциях, вызванных вирусом гриппа
CL2017000151A1 (es) Derivados de piridona
EA201690594A1 (ru) Состав для лечения вич-инфекции на основе атазанавира и кобицистата